Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 01 Oct 2026. Factsheet May 2026. About · Disclosures
Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment
Nippon India Mutual Fund₹171.9818
As on 01 Oct 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +4.14% | — | — |
| 3 year | +9.39% | — | — |
| 5 year | +7.46% | — | — |
- Sharpe
- 0.83
- Std dev
- 14.82%
- Beta
- 0.89
Returns
From NAVs through 01 Oct 2026
Calendar years
Rolling 1-year · 51 overlapping windows
Fund facts
Fund details from the May 2026 factsheet
Where the money is invested
Split by asset type.
By asset type
What the fund holds
39 holdings · portfolio as on 29 Apr 2026
- 13.85%Sun Pharmaceuticals Industries LtdHealthcare
- 7.95%Lupin LtdHealthcare
- 7.04%Dr Reddy's Laboratories LtdHealthcare
- 6.61%Divi's Laboratories LtdHealthcare
- 5.47%Cipla LtdHealthcare
- 5.01%Apollo Hospitals Enterprise LtdHealthcare
- 3.78%Medplus Health Services LtdHealthcare
- 3.36%Vijaya Diagnostic Centre LtdHealthcare
- 3.27%Sai Life Sciences LtdHealthcare
- 3.19%Ajanta Pharma LtdHealthcare
Concentration
Risk and quality measures
How steady the returns have been.
Return quality
Risk
Who manages this fund
3 fund managers
- LMLokesh Maru0.5 years in the industryRuns 43 schemes
- SRSailesh Raj Bhan20.9 years in the industryRuns 7 schemes
- DDDivya Dutt Sharma0.5 years in the industryRuns 43 schemes
SIP illustration
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
FAQ
What is Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment NAV today?
- The latest NAV of Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment is ₹171.9818 as on 01 Oct 2026.
How has Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment performed vs its category?
- 1-year return +4.14%. Past performance does not guarantee future returns.
What are the returns of Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment?
- Trailing returns from published NAVs: 1 year +4.14%, 3 year +9.39% a year, 5 year +7.46% a year, since our first NAV +8.10% a year. Past performance does not guarantee future returns.
How would a SIP in Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +9.39%. It is not a forecast.
What is the expense ratio and fund size of Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment?
- For Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment, the expense ratio is 0.80% and fund size (AUM) is ₹8365.40 Cr.
What is the ISIN of Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment?
- The ISIN for Nippon India Pharma Fund Direct Plan Dividend Plan IDCW Reinvestment is INF204K01I43.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.